Home›Products›Growth & Performance›Tesamorelin

📈

Technical Specifications

Purity

≥98%

Format

Lyophilized Powder

Storage

Lyophilized: 2–8°C. Reconstituted: 2–8°C up to 21 days.

✓ Certificate of Analysis IncludedUS Domestic Shipping
📈 Growth & Performance

Tesamorelin

FDA-studied GHRH analogue with visceral fat reduction research data.

Tesamorelin is a stabilized GHRH analogue with trans-3-hexenoic acid modification preventing enzymatic degradation. It is the most clinically studied GHRH analogue for HIV-associated lipodystrophy, generating an extensive body of FDA-reviewed research data on visceral adipose tissue reduction and IGF-1 normalization.

Research Applications

  • Trans-3-hexenoic acid stability
  • Visceral fat reduction research data
  • HIV-lipodystrophy clinical literature
  • IGF-1 normalization models
  • Metabolic restoration studies

Select Size

Price

$99

COA Included

🔒 Secure checkout · US domestic shipping · COA included

⚠️

Research Use Only. Not for human consumption, clinical, diagnostic, or veterinary use. For qualified researchers only.

Same Category

Related Compounds

View all Growth & Performance →
📈

Ipamorelin

The cleanest GH secretagogue — selective pulse, minimal side effects.

≥99% purity

From

$49

View →
📈

CJC-1295 (No DAC)

GHRH analogue for precise pulsatile GH amplification.

≥99% purity

From

$49

View →
📈

Sermorelin

First-generation GHRH analogue with decades of clinical research data.

≥98% purity

From

$49

View →